Management Options In Myasthenia Gravis

Update Item Information
Identifier 20020212_nanos_controversies_04
Title Management Options In Myasthenia Gravis
Creator Neil R. Miller
Affiliation Johns Hopkins University School of Medicine, Baltimore, MD
Subject Myasthenia Gravis; Muscle Weakness; Acetylcholine Receptors
Description The attendee will be able to describe the treatment options for patients with both generalized and ocular myasthenia gravis. Myasthenia gravis (MG) is a disease characterized clinically by muscle weakness and fatigability, attributable to too few available acetylcholine (ACh) receptors at neuromuscular junctions.
Date 2002-02-12
Language eng
Format application/pdf
Type Text
Source 2002 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS 2002: Hot Topics (Controversies)
Collection Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/
Publisher North American Neuro-Ophthalmology Society
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah
Rights Management Copyright 2002. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s6gb59kj
Setname ehsl_novel_nam
ID 181821
Reference URL https://collections.lib.utah.edu/ark:/87278/s6gb59kj
Back to Search Results